Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jeanne Gunzinger, Phoebe Moore, Athimalaipet Ramanan & Andrew Dick. (2021) Adalimumab in the treatment of pediatric patients with chronic noninfectious anterior uveitis. Expert Review of Ophthalmology 16:4, pages 231-241.
Read now
Read now
Articles from other publishers (16)
Stefania Cheli, Diego Savino, Annalisa De Silvestri, Lorenzo Norsa, Naire Sansotta, Francesca Penagini, Dario Dilillo, Roberto Panceri, Dario Cattaneo, Emilio Clementi & Giovanna Zuin. (2023) One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study. The Pharmacogenomics Journal.
Crossref
Crossref
Konstantinos Papamichael, Gabriele Stocco & Ainhoa Ruiz del Agua. (2023) Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases. Therapeutic Drug Monitoring Publish Ahead of Print.
Crossref
Crossref
Adam S. Cheifetz, Niels Vande Casteele, Zhongya Wang, Marla C. Dubinsky & Konstantinos Papamichael. (2023) Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn's Disease: A Post Hoc Analysis of the REACH Trial. American Journal of Gastroenterology 118:3, pages 485-490.
Crossref
Crossref
Elise Payen, Antoine Neuraz, Letizia Zenzeri, Cécile Talbotec, Elie Abi Nader, Lucienne Chatenoud, Stephanie Chhun, Olivier Goulet, Frank M. Ruemmele & Bénédicte Pigneur. (2022) Adalimumab Therapy in Pediatric Crohn Disease: A 2-Year Follow-Up Comparing “Top-Down” and “Step-Up” Strategies. Journal of Pediatric Gastroenterology & Nutrition 76:2, pages 166-173.
Crossref
Crossref
Marta Calvo Moya, Yago González Lama, Belén Ruíz Antorán, Ignacio Omella Usieto, Ismael el Hajra Martinez, Elena Santos Pérez, Belén Menchén Viso, Virginia Matallana Royo, Irene González Partida, Rocío de Lucas Tellez de Meneses, Pablo Bella Castillo, Macarena González Rodriguez & María Isabel Vera Mendoza. (2023) Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical Practice. Crohn's & Colitis 360 5:1.
Crossref
Crossref
Debora Curci, Marianna Lucafò, Pietro Parisse, Giuliana Decorti, Matteo Bramuzzo, Loredana Casalis & Gabriele Stocco. (2022) Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease. Journal of Personalized Medicine 12:6, pages 948.
Crossref
Crossref
RachelC Cogan, BasemW El-Matary & WaelM El-Matary. (2022) Therapeutic drug monitoring for biological medications in inflammatory bowel disease. Saudi Journal of Gastroenterology 28:5, pages 322.
Crossref
Crossref
Wenhui Hu, Yan Feng, Ziqing Ye, Zifei Tang, Lai Qian, Yuhuan Wang & Ying Huang. (2021) The Association Between Genetic Variants, Pharmacokinetics, and Infliximab Efficacy in Pediatric Patients With Crohn's Disease in China. Frontiers in Pediatrics 9.
Crossref
Crossref
Maya Zvuloni, Manar Matar, Rachel Levi, Dror S. Shouval, Raanan Shamir & Amit Assa. (2021) High anti-TNFα Concentrations Are Not Associated With More Adverse Events in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 73:6, pages 717-721.
Crossref
Crossref
Debora Curci, Marianna Lucafò, Adriana Cifù, Martina Fabris, Matteo Bramuzzo, Stefano Martelossi, Raffaella Franca, Giuliana Decorti & Gabriele Stocco. (2021) Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease. Clinical and Translational Science 14:6, pages 2184-2192.
Crossref
Crossref
Ji Tae Kim, Dana L. Napier, Jinhwan Kim, Chang Li, Eun Y. Lee, Heidi L. Weiss, Qingding Wang & B. Mark Evers. (2021) Ketogenesis alleviates TNFα-induced apoptosis and inflammatory responses in intestinal cells. Free Radical Biology and Medicine 172, pages 90-100.
Crossref
Crossref
Paulina Nuñez F.Rodrigo Quera, Daniela Simian, Lilian Flores, Carolina Figueroa, Patricio Ibañez, Udo Kronberg, Jaime Lubascher & Gonzalo Pizarro. (2021) Infliximab en enfermedad inflamatoria intestinal. ¿Es necesario premedicar?. Gastroenterología y Hepatología 44:5, pages 321-329.
Crossref
Crossref
Paulina Nuñez F.Rodrigo Quera, Daniela Simian, Lilian Flores, Carolina Figueroa, Patricio Ibañez, Udo Kronberg, Jaime Lubascher & Gonzalo Pizarro. (2021) Infliximab in inflammatory bowel disease. Is premedication necessary?. Gastroenterología y Hepatología (English Edition) 44:5, pages 321-329.
Crossref
Crossref
Patrick F van Rheenen, Marina Aloi, Amit Assa, Jiri Bronsky, Johanna C Escher, Ulrika L Fagerberg, Marco Gasparetto, Konstantinos Gerasimidis, Anne Griffiths, Paul Henderson, Sibylle Koletzko, Kaija-Leena Kolho, Arie Levine, Johan van Limbergen, Francisco Javier Martin de Carpi, Víctor Manuel Navas-López, Salvatore Oliva, Lissy de Ridder, Richard K Russell, Dror Shouval, Antonino Spinelli, Dan Turner, David Wilson, Eytan Wine & Frank M Ruemmele. (2021) The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update. Journal of Crohn's and Colitis 15:2, pages 171-194.
Crossref
Crossref
Jing-Jing Wang, Yi-Hong Fan & Rong Huang. (2020) Strengthened monitoring and optimized management of Crohn’s disease patients. World Chinese Journal of Digestology 28:15, pages 660-668.
Crossref
Crossref
Chang Li, Yuning Zhou, Piotr Rychahou, Heidi L. Weiss, Eun Y. Lee, Courtney L. Perry, Terrence A. Barrett, Qingding Wang & B. Mark Evers. (2020) SIRT2 Contributes to the Regulation of Intestinal Cell Proliferation and Differentiation. Cellular and Molecular Gastroenterology and Hepatology 10:1, pages 43-57.
Crossref
Crossref